FIVE PRIME THERAPEUTICS INC
Profile
Company Names
FIVE PRIME THERAPEUTICS INC
Addresses
TWO CORPORATE DRIVE, SOUTH SAN FRANCISCO, CA 94080
1650 OWENS STREET, SUITE 200, SAN FRANCISCO, CA 94158
Phone Numbers
415-365-5600
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
> 5 years ago
State Incorporated:
DELAWARE
Total Amount Raised:
$38,540,487.00
Number of Funding Rounds:
3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2014-03-19
$21,040,488.00
$21,040,488.00
$0.00
Equity
2
2012-04-16
$10,000,000.00
$10,000,000.00
$0.00
Equity
1
2010-08-03
$7,499,999.00
$7,499,999.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
BRIAN
ATWOOD
DIRECTOR
FRANKLIN
BERGER
DIRECTOR
FIVE PRIME THERAPEUTICS INC
| ITHERX PHARMA, INC.
| IMMUNE DESIGN CORP.
| ALZHEON, INC.
| ATRECA, INC.
| ESSA PHARMA INC.
| CERUS ENDOVASCULAR LTD
| KEZAR LIFE SCIENCES, INC.
| BELLUS HEALTH INC.
| APPLIED THERAPEUTICS INC.
| ATEA PHARMACEUTICALS, INC.
| RAIN THERAPEUTICS INC.
| WALKING FISH THERAPEUTICS, INC.
| SATELLOS BIOSCIENCE INC.
JAMES
BLAIR
DIRECTOR
BROOK
BYERS
DIRECTOR
OPTIMEDICA CORP
| HX DIAGNOSTICS INC
| CRESCENDO BIOSCIENCE, INC.
| CARDIODX INC
| VERACYTE, INC.
| FIVE PRIME THERAPEUTICS INC
| XDX, INC.
| ELCELYX THERAPEUTICS, INC.
| FOUNDATION MEDICINE, INC.
| OCULEVE, INC.
| ENJOY TECHNOLOGY, INC.
| ZEPHYR HEALTH, INC.
| NEWSELA, INC.
| CAREDX, INC.
| CELL DESIGN LABS, INC.
| GRAIL, INC.
| OCTAVE BIOSCIENCE INC
| EPIODYNE, INC.
| ARSENAL BIOSCIENCES, INC.
FRED
COHEN
DIRECTOR
PROTEOGENIX INC
| NODALITY INC
| NODALITY, INC.
| QUINTILES TRANSNATIONAL HOLDINGS INC.
| CARDIODX INC
| VERACYTE, INC.
| FIVE PRIME THERAPEUTICS INC
| XDX, INC.
| NOVAQUEST HEALTHCARE INVESTMENT FUND, L.P.
| REVAL HOLDINGS INC
| NOVAQUEST HEALTHCARE INVESTMENT FUND III, L.P.
| BNA CHICAGO LLC
| NOVAQUEST PHARMA OPPORTUNITIES FUND III, L.P.
| ROKA BIOSCIENCE, INC.
| RAPID MICRO BIOSYSTEMS, INC.
| AUXOGYN, INC.
| CAREDX, INC.
| PROGYNY, INC.
| CELL DESIGN LABS, INC.
| CHICKEN SOUP FOR THE SOUL ENTERTAINMENT, INC.
| VIDA VENTURES, LLC
| VVAG SPECIAL FUND LLC
| ASKLEPIOS BIOPHARMACEUTICAL, INC.
| VV ATREUS SPECIAL FUND LLC
| VIDA VENTURES II, LLC
| VIDA VENTURES II-A, LLC
| ASCEND GENE + CELL THERAPIES LTD.
| FIREFLY NEUROSCIENCE, INC.
| KYVERNA THERAPEUTICS, INC.
| ASCEND ADVANCED THERAPIES GROUP, INC.
| OLLIN BIOSCIENCES, INC.
JULIA
P.
GREGORY
EXECUTIVE OFFICER, DIRECTOR
MARK
MCDADE
DIRECTOR
LEWIS
T.
WILLIAMS
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2014-03-19
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
